A novel tissue-engineered decellularized and re-endothelialized human vascular graft for use in arterial bypass grafting.
Principal Investigator
Cristina Castells Sala
File
CPP2021-008438
Duration
2022 – 2025
Funded by
Agencia Estatal de Investigación
Funded by MICIU/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/ PRTR.
Objective
Development of a biological substitute of human origin for use as a revascularization graft, the VasCraft bioimplant, in coronary bypass surgeries